Global

Jul 26, 2017
Tensions are becoming clear within industry as it faces what might yet be the toughest negotiations on pricing with the UK government. Leela Barham reports.
Jul 21, 2017
Value frameworks are now "sexy". In the US, no fewer than five have emerged since 2015. Leela Barham discusses how the landscape is evolving.
Jul 18, 2017
The Association of the British Pharmaceutical Industry is seeking permission for a Judicial Review of NICE's affordability proposals. Leela Barham reports.
Jul 18, 2017
The Association of the British Pharmaceutical Industry has sought permission for a Judicial Review of the National Institute for Health and Care Excellence’s unpopular changes to tackle drug affordability.
Jul 12, 2017
Branded generics in select emerging markets can offer above-market returns, writes Renaud Savary.
Jun 27, 2017
Lana Sinichkina, Kateryna Oliinyk and Yevgeniya Ocheretko discuss how the recent settlement between Gilead and Ukraine's Ministry of Health could promote earlier market access in the country.
Jun 19, 2017
Pharmaceutical Executive
Last month’s EFPIA and EU Health Council annual conferences highlighted the growing divisions—and resentments—between industry and governments on drug pricing. Reflector reports.
Jun 02, 2017
With the UK's General Election set for June 8, Leela Barham looks what the competing parties are promising for pharma and healthcare
May 23, 2017
In the hothouse atmosphere of European governments' anxieties over ever more expensive medicines, recent weeks have seen perspiration breaking out on the brows of ministers, officials and drug company executives, writes Reflector.
native1_300x100
lorem ipsum